FORMULATION AND IN VITRO EVALUATION OF COMBINED FLOATING-BIOADHESIVE TABLETS OF IMATINIB MESYLATE
DOI:
https://doi.org/10.22159/ijpps.2017v9i11.18894Keywords:
Gastro-retentive, Imatinib mesylate, Swelling index, Bioadhesive strengthAbstract
Objective: Gastro retentive drug delivery system (GRDDS) pertaining to its attributes like gastric retention time and the extended drug release profile has significantly improved patient compliance. The objective of the present study is to formulate and evaluate a stomach-specific floating-bioadhesive tablet of imatinib mesylate for prolonged residence in the stomach in the treatment of gastrointestinal stromal tumors (GIST).
Methods: All the tablets were prepared with hydroxypropylmethylcellulose (HPMC), guar gum, sodium alginate, and carbopol using direct compression technique. Physical characterization, in vitro dissolution, the mucoadhesive force along with data analysis was done on each tablet.
Results: The pre-compression characteristics of powder mixtures found to be satisfactory for all formulation batches. The results of physical evaluation for all batches were complying with pharmacopeia specification. The swelling index for all formulation batches was approximately 100% after 8 hours. The bioadhesive force (mean ± SD) reported in a range of 0.05 ± 0.09 to 0.18 ± 0.06 N/m2. It was observed that the release rate of tablets was decreased when the viscosity and concentration of the polymer were increased. Formulation batches IB1, IB2, IB4, IB5, IB6, IB9, IB10, IB11, and IB13 follows Higuchi Matrix model kinetics; whereas IB3, IB7, IB8, and IB12 follows Korsmeyer- Peppas model kinetics.
Conclusion: Formulation batch IB9 reported a considerable swelling index, floating behavior, more bioadhesive strength with uniform drug release pattern. Therefore formulation batch IB9 was selected as optimized batch and were kept for further evaluation studies.
Downloads
References
Nayak AK, Maji R, Das B. Gastroretentive drug delivery systems: a review. Asian J Pharm Clin Res 2010;3:1-9
Chen YC, Ho HO, Liu DZ, Siow WS, Sheu MT. Swelling/floating capability and drug release characterizations of gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl cellulose. PloS one 2015; 10(1):e0116914
Panigrahy RN, Gudipati S, Chinnala KM. Design, development and in vitro evaluation of combined floating-bioadhesive drug delivery systems of atenolol. Int J Pharm Pharm Sci 2016; 8(2):41-6
Panigrahy RN, Mahale AM, Dhaked PS. Formulation and In Vitro Evaluation of Combined Floating-mucoadesive Tablet of Metoprolol Succinate. Int J Pharm Pharm Sci 2011;3(2):221-6
Mandal UK, Chatterjee B, Senjoti FG. Gastro-retentive drug delivery systems and their in vivo success: A recent update. Asian J Pharm Sci 2016;11(5):575-84
Panigrahy RN, Mahale AM, Sakarkar DM. Design development and in vitro testing of a combined bioadhesive-floating oral drug delivery system. J Pharm Res 2011;4(7):2212-5
Drug Bank: Imatinib (DB00619) [Internet]. Available: http://www.drugbank.ca/. [cited http://www.drugbank.ca/drugs/DB00619].
de Kogel CE, Schellens JH. Imatinib. Oncologist. 2007 Dec;12(12):1390-4
Kadivar A, Kamalidehghan B, Javar HA, Davoudi ET, Zaharuddin ND, Sabeti B, Chung LY, Noordin MI. Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet. PloS one. 2015;10(6):e0126874
The government of India, ministry of health and family welfare. The Pharmacopoeia of India. Controller of publication, 2014
(USP) TUSP. h711iDISSOLUTION. Apparatus 2 (Paddle Apparatus). Rockville, USA: The United States Pharmacopeial Convention (USP); 2011
Biswal B, Parmar H, Nayak J. Design development and evaluation of buccal tablet containing Nicorandil as a model drug. Int J Pharm Pharm Sci 2015;8(2):102-6
Published
How to Cite
Issue
Section
